FindTrial
Sign In

Efficacy and Safety of Oral Minoxidil in the treatment of Male Pattern Baldness

Efficacy and Safety Of Oral Minoxidil in the Treatment of Male Androgenetic Alopecia in a Tertiary Care Center - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/10/075292
Enrollment
55
Registered
2024-10-15
Start date
Unknown
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L649- Androgenic alopecia, unspecified

Interventions

Control Intervention1: NIL: NIL

Sponsors

Dr Farha P Nazeer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed with Male Androgenetic Alopecia with typical clinical presentation and trichoscopic finding. Patients between the age of 18 - 50 years

Exclusion criteria

Exclusion criteria: Those who are not willing for the study and who has been on treatment for hair loss for the past 3 months. Patient with cardiac disease and hypotension

Design outcomes

Primary

MeasureTime frame
Improvement in the parameters of the hair analysis namely the increase in the number of hairs per cm2 and increase in the hair diameter measured by Foto finder and an improvement in photographic assessment done by two independent observers Timepoint: 4 months—

Secondary

MeasureTime frame
Improvement in the patient satisfaction score analyzed by the questionnaireTimepoint: 4 months—

Countries

India

Contacts

Public ContactDr Naveen Thomas

Medical Trust Hospital

naveenthomas04@yahoo.com9731222763

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026